These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties. Bianco A; Hoebeke J; Godefroy S; Chaloin O; Pantarotto D; Briand JP; Muller S; Prato M; Partidos CD J Am Chem Soc; 2005 Jan; 127(1):58-9. PubMed ID: 15631447 [TBL] [Abstract][Full Text] [Related]
33. CpG oligodeoxinucleotides functions as an effective adjuvant in aged BALB/c mice. Maletto BA; Rópolo AS; Liscovsky MV; Alignani DO; Glocker M; Pistoresi-Palencia MC Clin Immunol; 2005 Dec; 117(3):251-61. PubMed ID: 16182607 [TBL] [Abstract][Full Text] [Related]
34. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs. Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685 [TBL] [Abstract][Full Text] [Related]
35. Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do. Najar HM; Dutz JP Eur J Immunol; 2007 Aug; 37(8):2242-56. PubMed ID: 17634951 [TBL] [Abstract][Full Text] [Related]
36. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Connolly JM; Hansen TH; Ingold AL; Potter TA Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2137-41. PubMed ID: 2107545 [TBL] [Abstract][Full Text] [Related]
37. Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer. Lubaroff DM; Karan D; Andrews MP; Acosta A; Abouassaly C; Sharma M; Krieg AM Vaccine; 2006 Aug; 24(35-36):6155-62. PubMed ID: 16876291 [TBL] [Abstract][Full Text] [Related]
38. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses. Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315 [TBL] [Abstract][Full Text] [Related]
39. Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL/6 mice. Chen YF; Lin CW; Tsao YP; Chen SL J Virol; 2004 Feb; 78(3):1333-43. PubMed ID: 14722288 [TBL] [Abstract][Full Text] [Related]
40. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides. Sauzet JP; Gras-Masse H; Guillet JG; Gomard E Int Immunol; 1996 Apr; 8(4):457-65. PubMed ID: 8671632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]